2024 | Current Diagnosis and Treatment of Acute Pancreatitis in Korea: A Nationwide Survey | GUT AND LIVER |
2024 | Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2024 | PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer | NPJ PRECISION ONCOLOGY |
2024 | Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
| BMC CANCER |
2024 | Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer
| SCIENTIFIC REPORTS |
2024 | Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
| BRITISH JOURNAL OF CANCER |
2024 | Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
| GENOME MEDICINE |
2024 | Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction
| AMERICAN JOURNAL OF GASTROENTEROLOGY |
2024 | Comparison of Physician-Controlled Maneuver and Assistant-Controlled Maneuver during Endoscopic Retrograde Cholangiopancreatography
| YONSEI MEDICAL JOURNAL |
2023 | Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
| FRONTIERS IN ONCOLOGY |
2023 | Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study
| SCIENTIFIC REPORTS |
2023 | Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreatic cancer clinical trial | STATISTICAL METHODS IN MEDICAL RESEARCH |
2023 | Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
2023 | Electrochemical detection and analysis of tumor-derived extracellular vesicles to evaluate malignancy of pancreatic cystic neoplasm using integrated microfluidic device | BIOSENSORS & BIOELECTRONICS |
2023 | Response | GASTROINTESTINAL ENDOSCOPY |
2023 | The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
| GUT AND LIVER |
2023 | Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis
| ADVANCED SCIENCE |
2023 | Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial | GASTROINTESTINAL ENDOSCOPY |
2023 | Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis
| GUT AND LIVER |
2023 | Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
| NATURE COMMUNICATIONS |
2023 | Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care
| YONSEI MEDICAL JOURNAL |
2022 | A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
| INTERNATIONAL JOURNAL OF CANCER |
2022 | Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
| CANCERS |
2022 | Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
| CANCERS |
2022 | Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial
| CANCERS |
2022 | Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study
| CANCERS |
2022 | Minimal and Maximal Extent of Band Ligation for Acute Variceal Bleeding during the First Endoscopic Session
| GUT AND LIVER |
2022 | Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
| GUT AND LIVER |
2022 | BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
| CANCERS |
2021 | GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
| BMC CANCER |
2021 | Optimal drainage of anastomosis stricture after living donor liver transplantation | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2021 | Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches | PANCREATOLOGY |
2021 | Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial
| JMIR MHEALTH AND UHEALTH |
2021 | Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer | EBIOMEDICINE |
2021 | Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
2020 | Comparative efficacy of stents in endoscopic ultrasonography-guided peripancreatic fluid collection drainage: A systematic review and network meta-analysis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2020 | FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma | PANCREAS |
2019 | A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
| PLoS One |
2019 | Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
| BMC MEDICAL GENOMICS |
2019 | Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2019 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2019 | Same-session endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary obstruction: A multicenter experience | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2018 | Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2018 | Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study | SEMINARS IN ONCOLOGY |